Eledon Pharmaceuticals, Inc.
ELDN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001404281
No open-market purchases or sales by Eledon Pharmaceuticals, Inc. insiders were filed in the last 90 days; 161 institutions reported holding it in 13F filings for Q2 2026, worth $184.6M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Eledon Pharmaceuticals, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 83 | 1 | 95 | +13 |
| Shares | 36.5M | 59.6K | 44.2M | +7.74M (+21.3%) |
| Value | $94.5M | $151.3K | $66.7M | −$27.6M (−29.3%) |
1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (32)
Institutions that held Eledon Pharmaceuticals, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
Sold out (19)
Institutions that held Eledon Pharmaceuticals, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Ra Capital Management, L.P. | 3,566,338 | $9.24M |
| Siren, L.L.C. | 2,072,767 | $5.37M |
| Wellington Management Group LLP | 1,283,939 | $3.33M |
| Nantahala Capital Management, LLC | 1,141,237 | $2.96M |
| Woodline Partners LP | 800,822 | $2.07M |
| Kovitz Investment Group Partners, LLC | 732,975 | $1.90M |
| Velan Capital Investment Management LP | 346,973 | $898.7K |
| Deutsche Bank AG | 64,110 | $166.0K |
| Brighton Jones LLC | 39,355 | $101.9K |
| Squarepoint Ops LLC | 36,297 | $94.0K |
| Bridgeway Capital Management, LLC | 33,400 | $86.5K |
| American Century Companies Inc | 21,572 | $55.9K |
| Manufacturers Life Insurance Company, The | 19,072 | $49.4K |
| Panagora Asset Management Inc | 18,628 | $48.2K |
| Simplex Trading, LLC | 15,997 | $41.0K |
| Catalyst Funds Management Pty Ltd | 11,400 | $29.5K |
| Group One Trading, L.P. | 4,217 | $10.9K |
| Redwood Park Advisors LLC | 700 | $1.81K |
| SRS Capital Advisors, Inc. | 152 | $393 |
Not filed for Q4 2025 yet (1)
Institutions that held Eledon Pharmaceuticals, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Wolverine Trading, LLC | 59,574 | $151.3K |